STXS: Stereotaxis Company Sales Revenue

High clinic loyalty to Stereotaxis, Inc. (STXS) is driven by the specifics of staff training and FDA certification. Proprietary Genesis software creates a strong lock-in for hospitals to the equipment, which is confirmed by the company's sales profile on GURU.Markets, where 0.03 captures the current indicator value. Its status as a global leader in robotic cardiology guarantees the brand impeccable authority due to maximum surgical precision.

Revenue and Sales Volume: Stereotaxis (STXS) for 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Stereotaxis (STXS)

- current price and projected stock value:

Share Price Stereotaxis Corporation|STXS - Consensus Target

- market capitalization information:

Market Value Stereotaxis, Inc.|STXS - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Stereotaxis|STXS - Book Capitalization|Market-to-Book Ratio stereotaxis.com|STXS - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

STXS - Net Income|Expected Net Income Stereotaxis, Inc.|STXS - P/E Multiple|Projected Price to Earnings Ratio stereotaxis.com|STXS - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Stereotaxis, Inc.|STXS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Stereotaxis|STXS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months stereotaxis.com|STXS - Earnings per share growth in current year|Net earnings per share change forecast for next year Stereotaxis, Inc.

- company sales and revenue statistics:

STXS - Company Revenue|Company Future Sales Volume Stereotaxis Corporation|STXS - P/S Multiple|Market Cap to Future Revenue Ratio Stereotaxis, Inc.

Summary company analysis:STXS Stereotaxis Corporation

Stereotaxis, Inc. (STXS) sales measure the total cash inflow from the sale of goods and services, reflecting the pace of business expansion. For Stereotaxis, Inc. (STXS), this flow is generated through the implementation of Genesis robotic systems and the sale of associated consumables. By analyzing the company's sales time series, an investor can observe the commercialization dynamics of cardiology technologies. The current value of this indicator is 0.03. This metric serves as a fundamental indicator of market product adoption and the potential for revenue scaling.

Key competitors